Swiss National Bank Moderna, Inc. Transaction History

Swiss National Bank

$143 Billion
Q2 2024

A detailed history of Swiss National Bank transactions in Moderna, Inc. stock. As of the latest transaction made, Swiss National Bank holds 963,600 shares of MRNA stock, worth $63.4 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

963,600

Previous 970,600 0.72%

Holding current value

$63.4 Million

Previous $103 Million 10.64%

% of portfolio

0.08%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$101.21 - $166.61 $708,470 - $1.17 Million	-7,000 Reduced 0.72%	963,600 $114 Million
Q1 2024 May 07, 2024	SELL	$85.37 - $115.44 $3.5 Million - $4.73 Million	-41,000 Reduced 4.05%	970,600 $103 Million
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $2.13 Million - $3.21 Million	-30,700 Reduced 2.95%	1,011,600 $101 Million
Q3 2023 Nov 08, 2023	SELL	$96.41 - $126.61 $13.7 Million - $17.9 Million	-141,700 Reduced 11.97%	1,042,300 $108 Million
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $13.3 Million - $18 Million	-112,000 Reduced 8.64%	1,184,000 $144 Million
Q1 2023 May 10, 2023	SELL	$135.66 - $197.02 $7.52 Million - $10.9 Million	-55,400 Reduced 4.1%	1,296,000 $199 Million
Q4 2022 Feb 08, 2023	SELL	$118.38 - $210.04 $13.5 Million - $23.9 Million	-113,800 Reduced 7.77%	1,351,400 $243 Million
Q3 2022 Nov 09, 2022	SELL	$118.07 - $194.18 $2.4 Million - $3.94 Million	-20,300 Reduced 1.37%	1,465,200 $173 Million
Q2 2022 Aug 09, 2022	SELL	$117.13 - $176.59 $843,336 - $1.27 Million	-7,200 Reduced 0.48%	1,485,500 $212 Million
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $23.9 Million - $44.3 Million	188,600 Added 14.46%	1,492,700 $257 Million
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $10.3 Million - $16.7 Million	-45,400 Reduced 3.36%	1,304,100 $331 Million
Q3 2021 Nov 08, 2021	BUY	$221.9 - $484.47 $13 Million - $28.4 Million	58,600 Added 4.54%	1,349,500 $519 Million
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $18.8 Million - $34 Million	144,800 Added 12.63%	1,290,900 $303 Million
Q1 2021 May 07, 2021	BUY	$109.18 - $185.98 $11.3 Million - $19.2 Million	103,200 Added 9.9%	1,146,100 $150 Million
Q4 2020 Feb 05, 2021	SELL	$65.74 - $169.86 $1.08 Million - $2.8 Million	-16,500 Reduced 1.56%	1,042,900 $109 Million
Q3 2020 Nov 09, 2020	BUY	$54.34 - $94.85 $1.55 Million - $2.7 Million	28,500 Added 2.76%	1,059,400 $75 Million
Q2 2020 Aug 05, 2020	BUY	$29.67 - $80.0 $30.6 Million - $82.5 Million	1,030,900 New	1,030,900 $66.2 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Moderna, Inc. Transaction History